{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:12:52Z","timestamp":1790230372095,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.ejpb.2020.10.012","type":"journal-article","created":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T19:16:01Z","timestamp":1603566961000},"page":"233-240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["An ultrasound responsive microbubble-liposome conjugate for targeted irinotecan-oxaliplatin treatment of pancreatic cancer"],"prefix":"10.1016","volume":"157","author":[{"given":"Jinhui","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Nesbitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiran","family":"Logan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Burnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bronagh","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain G.","family":"Jack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Love","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridgeen","family":"Callan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony P.","family":"McHale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Callan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2020.10.012_b0005","unstructured":"Cancer Research UK. (2020).Pancreatic cancer statistics. [online] Available at: [Accessed 2 Feb. 2020]. https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/pancreatic-cancer."},{"key":"10.1016\/j.ejpb.2020.10.012_b0010","unstructured":"Gemcitabine plus nab-paclitaxel improves survival in pancreatic cancer, 2013.The Pharmaceutical Journal."},{"issue":"1","key":"10.1016\/j.ejpb.2020.10.012_b0015","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-018-5240-6","article-title":"Nab-paclitaxel and gemcitabine or FOLFIRINOX as first-line treatment in patients with unresectable adenocarcinoma of the pancreas: does sequence matter?","volume":"19","author":"Vogl","year":"2019","journal-title":"BMC Cancer"},{"issue":"10","key":"10.1016\/j.ejpb.2020.10.012_b0020","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1007\/s12325-018-0784-z","article-title":"Comparative Effectiveness of nab-Paclitaxel Plus Gemcitabine vs FOLFIRINOX in Metastatic Pancreatic Cancer: A Retrospective Nationwide Chart Review in the United States","volume":"35","author":"Kim","year":"2018","journal-title":"Adv. Therapy"},{"issue":"5","key":"10.1016\/j.ejpb.2020.10.012_b0025","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2217\/fon.15.335","article-title":"The role of neoadjuvant therapy in pancreatic cancer: a review","volume":"12","author":"Russo","year":"2016","journal-title":"Future Oncol."},{"issue":"7","key":"10.1016\/j.ejpb.2020.10.012_b0030","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.3390\/ijms18071338","article-title":"Pancreatic Ductal Adenocarcinoma: Current and Evolving Therapies","volume":"18","author":"Adamska","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.ejpb.2020.10.012_b0035","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1517\/17425247.5.10.1121","article-title":"Ultrasound targeted microbubble destruction for drug and gene delivery","volume":"5","author":"Mayer","year":"2008","journal-title":"Expert Opin. Drug Deliv."},{"issue":"1","key":"10.1016\/j.ejpb.2020.10.012_b0040","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/2050-5736-1-10","article-title":"Ultrasound-targeted microbubble destruction for chemotherapeutic drug delivery to solid tumors","volume":"1","author":"Chen","year":"2013","journal-title":"J. Ther. Ultrasound"},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2020.10.012_b0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1179\/175889709X446507","article-title":"Microbubble compositions, properties and biomedical applications","volume":"1","author":"Sirsi","year":"2009","journal-title":"Bubble Sci. Eng. Technol."},{"issue":"14","key":"10.1016\/j.ejpb.2020.10.012_b0050","doi-asserted-by":"crossref","DOI":"10.1088\/0031-9155\/54\/14\/C01","article-title":"Ultrasound contrast microbubbles in imaging and therapy: physical principles and engineering","volume":"54","author":"Qin","year":"2009","journal-title":"Phys. Med. Biol."},{"issue":"4","key":"10.1016\/j.ejpb.2020.10.012_b0055","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0301-5629(02)00787-1","article-title":"On the destruction of microbubble ultrasound contrast agents","volume":"29","author":"Stride","year":"2003","journal-title":"Ultrasound Med. Biol."},{"issue":"3","key":"10.1016\/j.ejpb.2020.10.012_b0060","doi-asserted-by":"crossref","first-page":"171","DOI":"10.14366\/usg.17021","article-title":"Ultrasound-guided drug delivery in cancer","volume":"36","author":"Mullick Chowdhury","year":"2017","journal-title":"Ultrasonography"},{"issue":"4","key":"10.1016\/j.ejpb.2020.10.012_b0065","doi-asserted-by":"crossref","first-page":"467","DOI":"10.4155\/tde.14.10","article-title":"Mechanisms of microbubble-facilitated sonoporation for drug and gene delivery","volume":"5","author":"Fan","year":"2014","journal-title":"Therapeut. Deliv."},{"issue":"6","key":"10.1016\/j.ejpb.2020.10.012_b0070","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1177\/1756283X15592584","article-title":"Therapeutic potential of ultrasound microbubbles in gastrointestinal oncology: recent advances and future prospects","volume":"8","author":"Khokhlova","year":"2015","journal-title":"Therapeut. Adv. Gastroenterol."},{"key":"10.1016\/j.ejpb.2020.10.012_b0075","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.biomaterials.2015.11.033","article-title":"Combined sonodynamic and antimetabolite therapy for the improved treatment of pancreatic cancer using oxygen loaded microbubbles as a delivery vehicle","volume":"80","author":"McEwan","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2020.10.012_b0080","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jconrel.2017.07.040","article-title":"Magnetically responsive microbubbles as delivery vehicles for targeted sonodynamic and antimetabolite therapy of pancreatic cancer","volume":"262","author":"Sheng","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2020.10.012_b0085","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jconrel.2018.04.018","article-title":"Gemcitabine loaded microbubbles for targeted chemo-sonodynamic therapy of pancreatic cancer","volume":"279","author":"Nesbitt","year":"2018","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ejpb.2020.10.012_b0090","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/1758834010388342","article-title":"Balancing the efficacy and toxicity of chemotherapy in colorectal cancer","volume":"3","author":"Braun","year":"2010","journal-title":"Therapeutic Adv. Med. Oncol."},{"issue":"1","key":"10.1016\/j.ejpb.2020.10.012_b0095","doi-asserted-by":"crossref","DOI":"10.3747\/co.v18i1.708","article-title":"Oxaliplatin: a review in the era of molecularly targeted therapy","volume":"18","author":"Alcindor","year":"2011","journal-title":"Current Oncol."},{"issue":"12","key":"10.1016\/j.ejpb.2020.10.012_b0100","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1093\/annonc\/mdf337","article-title":"Irinotecan: mechanisms of tumor resistance and novel strategies for modulating its activity","volume":"13","author":"Xu","year":"2002","journal-title":"Ann. Oncol."},{"issue":"11","key":"10.1016\/j.ejpb.2020.10.012_b0105","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1039\/b823051j","article-title":"Drug loaded microbubble design for ultrasound triggered delivery","volume":"5","author":"Lentacker","year":"2009","journal-title":"Soft Matter"},{"issue":"3","key":"10.1016\/j.ejpb.2020.10.012_b0110","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.yexmp.2008.12.004","article-title":"Nanoparticle-based targeted drug delivery","volume":"86","author":"Singh","year":"2009","journal-title":"Exp. Mol. Pathol."},{"issue":"2","key":"10.1016\/j.ejpb.2020.10.012_b0115","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1016\/j.ddtec.2011.11.010","article-title":"Enhanced permeability and retention effect for selective targeting of anticancer nanomedicine: are we there yet?","volume":"9","author":"Greish","year":"2012","journal-title":"Drug Discovery Today Technolog."},{"issue":"1","key":"10.1016\/j.ejpb.2020.10.012_b0120","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7150\/thno.7193","article-title":"Improving Conventional Enhanced Permeability and Retention (EPR) Effects; What Is the Appropriate Target?","volume":"4","author":"Kobayashi","year":"2014","journal-title":"Theranostics"},{"issue":"2","key":"10.1016\/j.ejpb.2020.10.012_b0125","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1260\/2040-2295.4.2.223","article-title":"Ultrasound-Mediated Drug\/Gene Delivery in Solid Tumor Treatment","volume":"4","author":"Zhou","year":"2013","journal-title":"J. Healthcare Eng."},{"issue":"3","key":"10.1016\/j.ejpb.2020.10.012_b0130","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/nprot.2006.238","article-title":"Analysis of apoptosis by propidium iodide staining and flow cytometry","volume":"1","author":"Riccardi","year":"2006","journal-title":"Nat. Protoc."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641120303131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641120303131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:42:02Z","timestamp":1760546522000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641120303131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":26,"alternative-id":["S0939641120303131"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2020.10.012","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An ultrasound responsive microbubble-liposome conjugate for targeted irinotecan-oxaliplatin treatment of pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2020.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}